Thomas Hilser

Essen, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

LLM-Generated Lay-Language Protocols for Molecular Tumor Board Patients: Evaluation of Quality and Clinical Usability.

LLM-Generated Lay-Language Protocols for Molecular Tumor Board Patients: Evaluation of Quality and Clinical Usability.

Journal: Journal of medical Internet research

Published: April 22, 2026

Histotype-specific incidence and survival of urothelial carcinoma-an analysis of the German North Rhine-Westphalia Cancer Registry.

Histotype-specific incidence and survival of urothelial carcinoma-an analysis of the German North Rhine-Westphalia Cancer Registry.

Journal: ESMO real world data and digital oncology

Published: April 03, 2026

Real-world efficacy and toxicity of ipilimumab and nivolumab as a first-line treatment for advanced renal cell carcinoma according to IMDC risk criteria-A multi-center retrospective analysis on behalf of the GUARDIANS group.

Real-world efficacy and toxicity of ipilimumab and nivolumab as a first-line treatment for advanced renal cell carcinoma according to IMDC risk criteria-A multi-center retrospective analysis on behalf of the GUARDIANS group.

Journal: International journal of cancer

Published: July 03, 2025

Real-world Evidence from a Retrospective Multicentre Analysis on First-line Therapy for Metastatic Papillary Renal Cell Carcinoma. A GUARDIANS Project.

Real-world Evidence from a Retrospective Multicentre Analysis on First-line Therapy for Metastatic Papillary Renal Cell Carcinoma. A GUARDIANS Project.

Journal: European urology open science

Published: June 22, 2025

Immune-related hepatic adverse events in renal cell carcinoma patients treated with immune checkpoint inhibitors: a retrospective study.

Immune-related hepatic adverse events in renal cell carcinoma patients treated with immune checkpoint inhibitors: a retrospective study.

Journal: BJC reports

Published: April 07, 2025

ABO-Blood Group Associates With Survival Outcomes in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy.

ABO-Blood Group Associates With Survival Outcomes in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy.

Journal: Thoracic cancer

Published: January 21, 2025

From BERT to generative AI - Comparing encoder-only vs. large language models in a cohort of lung cancer patients for named entity recognition in unstructured medical reports.

From BERT to generative AI - Comparing encoder-only vs. large language models in a cohort of lung cancer patients for named entity recognition in unstructured medical reports.

Journal: Computers in biology and medicine

Published: January 08, 2025

Treatment of Advanced or Metastatic Urothelial Cancer.

Treatment of Advanced or Metastatic Urothelial Cancer.

Journal: Oncology research and treatment

Published: January 07, 2025

Contemporary treatment of metastatic clear cell renal cell carcinoma

Contemporary treatment of metastatic clear cell renal cell carcinoma

Journal: Urologie (Heidelberg, Germany)

Published: October 11, 2024

Cabozantinib Plus Nivolumab in Adult Patients with Advanced or Metastatic Renal Cell Carcinoma: A Retrospective, Non-Interventional Study in a Real-World Cohort/GUARDIANS Project.

Cabozantinib Plus Nivolumab in Adult Patients with Advanced or Metastatic Renal Cell Carcinoma: A Retrospective, Non-Interventional Study in a Real-World Cohort/GUARDIANS Project.

Journal: Cancers

Published: July 22, 2024

PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors.

PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 26, 2024

Emergencies in cancer immunotherapy

Emergencies in cancer immunotherapy

Journal: Aktuelle Urologie

Published: August 22, 2023

Showing 1-12 of 19

Last Updated: 09/26/2026